792 related articles for article (PubMed ID: 17255201)
1. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
2. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Shimizu T; Tada Y; Watanabe S
Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
[TBL] [Abstract][Full Text] [Related]
3. Essential involvement of cross-talk between IFN-gamma and TNF-alpha in CXCL10 production in human THP-1 monocytes.
Qi XF; Kim DH; Yoon YS; Jin D; Huang XZ; Li JH; Deung YK; Lee KJ
J Cell Physiol; 2009 Sep; 220(3):690-7. PubMed ID: 19472212
[TBL] [Abstract][Full Text] [Related]
4. Leptin enhances human beta-defensin-2 production in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2008 Oct; 149(10):5189-98. PubMed ID: 18556347
[TBL] [Abstract][Full Text] [Related]
5. TNFSF14 coordinately enhances CXCL10 and CXCL11 productions from IFN-gamma-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Mol Immunol; 2010 Jan; 47(4):666-70. PubMed ID: 19939453
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin Inhibits Interferon-γ-Inducible Genes Expression in Hepatocytes through Down-Regulating Activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt Signaling Pathways.
Wu S; Xue J; Yang Y; Zhu H; Chen F; Wang J; Lou G; Liu Y; Shi Y; Yu Y; Xia C; Hu Y; Chen Z
Cell Physiol Biochem; 2015; 37(2):501-14. PubMed ID: 26315837
[TBL] [Abstract][Full Text] [Related]
7. Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines.
Hiroi M; Ohmori Y
Biochem J; 2003 Dec; 376(Pt 2):393-402. PubMed ID: 12946268
[TBL] [Abstract][Full Text] [Related]
8. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.
Tan X; Alrashdan YA; Alkhouri H; Oliver BG; Armour CL; Hughes JM
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L790-802. PubMed ID: 23564506
[TBL] [Abstract][Full Text] [Related]
9. Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes.
Kanda N; Hau CS; Tada Y; Tatsuta A; Sato S; Watanabe S
Endocrinology; 2011 Aug; 152(8):3155-64. PubMed ID: 21673103
[TBL] [Abstract][Full Text] [Related]
10. Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 3-O-β-D-glucopyanosylspinasterol via blocking NF-κB and STAT1 signaling pathways in TNF-α and IFN-γ-induced HaCaT keratinocytes.
Jung MR; Lee TH; Bang MH; Kim H; Son Y; Chung DK; Kim J
Biochem Biophys Res Commun; 2012 Oct; 427(2):236-41. PubMed ID: 22943853
[TBL] [Abstract][Full Text] [Related]
11. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.
Kanda N; Shibata S; Tada Y; Nashiro K; Tamaki K; Watanabe S
Eur J Immunol; 2009 Apr; 39(4):996-1006. PubMed ID: 19350575
[TBL] [Abstract][Full Text] [Related]
12. 17beta-estradiol inhibits the production of interferon-induced protein of 10 kDa by human keratinocytes.
Kanda N; Watanabe S
J Invest Dermatol; 2003 Mar; 120(3):411-9. PubMed ID: 12603854
[TBL] [Abstract][Full Text] [Related]
13. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
Panzer U; Zahner G; Wienberg U; Steinmetz OM; Peters A; Turner JE; Paust HJ; Wolf G; Stahl RA; Schneider A
Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
[TBL] [Abstract][Full Text] [Related]
14. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
[TBL] [Abstract][Full Text] [Related]
15. Acute alcohol intoxication suppresses the pulmonary ELR-negative CXC chemokine response to lipopolysaccharide.
Happel KI; Rudner X; Quinton LJ; Movassaghi JL; Clark C; Odden AR; Zhang P; Bagby GJ; Nelson S; Shellito JE
Alcohol; 2007 Aug; 41(5):325-33. PubMed ID: 17889309
[TBL] [Abstract][Full Text] [Related]
16. The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes.
Qi XF; Kim DH; Yoon YS; Li JH; Song SB; Jin D; Huang XZ; Teng YC; Lee KJ
Mol Immunol; 2009 Jun; 46(10):1925-34. PubMed ID: 19371952
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
18. Cepharanthine Inhibits IFN-γ-Induced CXCL10 by Suppressing the JAK2/STAT1 Signal Pathway in Human Salivary Gland Ductal Cells.
Aota K; Yamanoi T; Kani K; Azuma M
Inflammation; 2018 Feb; 41(1):50-58. PubMed ID: 28879548
[TBL] [Abstract][Full Text] [Related]
19. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
[TBL] [Abstract][Full Text] [Related]
20. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
